4-butyrolactone has been researched along with Animal Mammary Carcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowers, LW; Camp, KK; Fabian, CJ; Ford, NA; Hursting, SD; Kimler, BK; Lineberger, CG; Punjala, A; Rossi, EL | 1 |
| Arenas, C; Granados-Soler, JL; Peña, L; Pérez-Alenza, MD | 1 |
| Ammälä, J; Collan, YU; Eckerman, C; Huovinen, R; Lehtilä, R; Mäkelä, SI; Saarinen, NM; Santti, RS; Sjöholm, R; Valentín-Blasini, L; Wärri, A | 1 |
| Alli, PM; Jaffee, EM; Kuhajda, FP; McFadden, JM; Pinn, ML | 1 |
| Chen, JM; Power, KA; Saarinen, NM; Thompson, LU; Ward, WE | 1 |
| Arant, M; El Sayed, K; Mayer, A; Sawant, S; Sylvester, P; Wali, V; Youssef, D | 1 |
| Airio, M; Mäkelä, S; Saarinen, NM; Smeds, A; Wärri, A | 1 |
1 review(s) available for 4-butyrolactone and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Role of dietary lignans in the reduction of breast cancer risk.
Topics: 4-Butyrolactone; Animals; Anticarcinogenic Agents; Bacteria; Breast Neoplasms; Cell Division; Diet; Female; Humans; Intestines; Lignans; Mammary Neoplasms, Animal; Plants, Edible; Risk Factors | 2007 |
6 other study(ies) available for 4-butyrolactone and Animal Mammary Carcinoma
| Article | Year |
|---|---|
The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Biomarkers; Butylene Glycols; Cell Line, Tumor; Cell Survival; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flax; Gene Expression Profiling; Glucosides; Immunohistochemistry; Lignans; Mammary Neoplasms, Animal; Mice; NF-kappa B; Signal Transduction | 2019 |
Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Case-Control Studies; Chemotherapy, Adjuvant; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Female; Mammary Neoplasms, Animal; Mitoxantrone; Prospective Studies; Sulfones; Treatment Outcome | 2016 |
Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat.
Topics: 4-Butyrolactone; 9,10-Dimethyl-1,2-benzanthracene; Animals; Aromatase Inhibitors; Carcinogens; Cell Division; Enzyme Inhibitors; Estrogens; Estrogens, Non-Steroidal; Female; Isoflavones; Lignans; Mammary Neoplasms, Animal; Models, Chemical; Organ Size; Phytoestrogens; Plant Preparations; Rats; Rats, Sprague-Dawley; Time Factors; Uterus | 2002 |
Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.
Topics: 4-Butyrolactone; Animals; DNA-Binding Proteins; fas Receptor; Fatty Acid Synthases; Female; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Nerve Tissue Proteins; Nuclear Proteins; Receptors, Tumor Necrosis Factor; Tumor Cells, Cultured | 2005 |
Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Bone and Bones; Bone Density; Drug Combinations; Estrogens; Female; Genistein; Humans; Lignans; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Nude; Organ Size; Ovariectomy; Phytoestrogens; Postmenopause; Uterus; Xenograft Model Antitumor Assays | 2006 |
Anticancer and anti-inflammatory sulfur-containing semisynthetic derivatives of sarcophine.
Topics: 4-Butyrolactone; Animals; Anthozoa; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Mass Spectrometry; Mice; Molecular Structure; Rats; Sulfur | 2006 |